A biotechnology startup that promises to resurrect woolly mammoths is now the first “de-extinction unicorn”, with a valuation said to be over a US$1bil (RM4.26bil) before bringing back a single lost species. Colossal Biosciences, the Dallas-based startup, is making public a new round of investment this week that will help fund its effort to bring back perhaps the most famously extinct animal of them all: the dodo.
Reintroducing mammoths to Alaska or dodos to Mauritius sounds unrealistic, even silly, and has drawn scepticism from paleo-geneticists and other experts who worry that the effects of de-extinction would be unpredictable. Yet Colossal has continued to draw support from investors, including celebrities, and on Jan 31 announced another US$150mil (RM639.87mil) for a total of US$225mil (RM959.80mil) since 2021. A person familiar with the company said with the latest round the startup is valued at about US$1.5bil (RM6.39bil).
Already a subscriber? Log in
5.5 PAYDAY OFFER: 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
